Global Biosimilars Drug Supply, Demand and Key Producers, 2023-2029
The global Biosimilars Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
This report studies the global Biosimilars Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biosimilars Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biosimilars Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biosimilars Drug total market, 2018-2029, (USD Million)
Global Biosimilars Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biosimilars Drug total market, key domestic companies and share, (USD Million)
Global Biosimilars Drug revenue by player and market share 2018-2023, (USD Million)
Global Biosimilars Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Biosimilars Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Biosimilars Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, Shanghai Henlius, Innovent Biologics, Jiangsu Hengrui, Gan&Lee, Tonghua Dongbao and United Laboratory, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biosimilars Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biosimilars Drug Market, By Region:
1. How big is the global Biosimilars Drug market?
2. What is the demand of the global Biosimilars Drug market?
3. What is the year over year growth of the global Biosimilars Drug market?
4. What is the total value of the global Biosimilars Drug market?
5. Who are the major players in the global Biosimilars Drug market?
6. What are the growth factors driving the market demand?
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
This report studies the global Biosimilars Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biosimilars Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biosimilars Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biosimilars Drug total market, 2018-2029, (USD Million)
Global Biosimilars Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biosimilars Drug total market, key domestic companies and share, (USD Million)
Global Biosimilars Drug revenue by player and market share 2018-2023, (USD Million)
Global Biosimilars Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Biosimilars Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Biosimilars Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, Shanghai Henlius, Innovent Biologics, Jiangsu Hengrui, Gan&Lee, Tonghua Dongbao and United Laboratory, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biosimilars Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biosimilars Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monoclonal Antibodies
- Insulin
- Others
- Hospital
- Retail Pharmacy
- Other
- Qilu Pharmaceutical
- Bio-Thera
- Zhejiang Hisun
- Shanghai Henlius
- Innovent Biologics
- Jiangsu Hengrui
- Gan&Lee
- Tonghua Dongbao
- United Laboratory
- 3SBIO
- Luye Pharma
- Celltrion
- Pfizer
- Novartis
- Dr Reddy’s
- Celgen Biopharma
- Eli Lilly
- Sanofi
- Geropharm
- Biocon
- Wockhardt
1. How big is the global Biosimilars Drug market?
2. What is the demand of the global Biosimilars Drug market?
3. What is the year over year growth of the global Biosimilars Drug market?
4. What is the total value of the global Biosimilars Drug market?
5. Who are the major players in the global Biosimilars Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Biosimilars Drug Introduction
1.2 World Biosimilars Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Biosimilars Drug Total Market by Region (by Headquarter Location)
1.3.1 World Biosimilars Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Biosimilars Drug Market Size (2018-2029)
1.3.3 China Biosimilars Drug Market Size (2018-2029)
1.3.4 Europe Biosimilars Drug Market Size (2018-2029)
1.3.5 Japan Biosimilars Drug Market Size (2018-2029)
1.3.6 South Korea Biosimilars Drug Market Size (2018-2029)
1.3.7 ASEAN Biosimilars Drug Market Size (2018-2029)
1.3.8 India Biosimilars Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biosimilars Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biosimilars Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biosimilars Drug Consumption Value (2018-2029)
2.2 World Biosimilars Drug Consumption Value by Region
2.2.1 World Biosimilars Drug Consumption Value by Region (2018-2023)
2.2.2 World Biosimilars Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Biosimilars Drug Consumption Value (2018-2029)
2.4 China Biosimilars Drug Consumption Value (2018-2029)
2.5 Europe Biosimilars Drug Consumption Value (2018-2029)
2.6 Japan Biosimilars Drug Consumption Value (2018-2029)
2.7 South Korea Biosimilars Drug Consumption Value (2018-2029)
2.8 ASEAN Biosimilars Drug Consumption Value (2018-2029)
2.9 India Biosimilars Drug Consumption Value (2018-2029)
3 WORLD BIOSIMILARS DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Biosimilars Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biosimilars Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biosimilars Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Biosimilars Drug in 2022
3.3 Biosimilars Drug Company Evaluation Quadrant
3.4 Biosimilars Drug Market: Overall Company Footprint Analysis
3.4.1 Biosimilars Drug Market: Region Footprint
3.4.2 Biosimilars Drug Market: Company Product Type Footprint
3.4.3 Biosimilars Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biosimilars Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biosimilars Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Biosimilars Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Biosimilars Drug Consumption Value Comparison
4.2.1 United States VS China: Biosimilars Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biosimilars Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Biosimilars Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Biosimilars Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biosimilars Drug Revenue, (2018-2023)
4.4 China Based Companies Biosimilars Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Biosimilars Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biosimilars Drug Revenue, (2018-2023)
4.5 Rest of World Based Biosimilars Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Biosimilars Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biosimilars Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biosimilars Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibodies
5.2.2 Insulin
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Biosimilars Drug Market Size by Type (2018-2023)
5.3.2 World Biosimilars Drug Market Size by Type (2024-2029)
5.3.3 World Biosimilars Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biosimilars Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Biosimilars Drug Market Size by Application (2018-2023)
6.3.2 World Biosimilars Drug Market Size by Application (2024-2029)
6.3.3 World Biosimilars Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Qilu Pharmaceutical
7.1.1 Qilu Pharmaceutical Details
7.1.2 Qilu Pharmaceutical Major Business
7.1.3 Qilu Pharmaceutical Biosimilars Drug Product and Services
7.1.4 Qilu Pharmaceutical Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Qilu Pharmaceutical Recent Developments/Updates
7.1.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
7.2 Bio-Thera
7.2.1 Bio-Thera Details
7.2.2 Bio-Thera Major Business
7.2.3 Bio-Thera Biosimilars Drug Product and Services
7.2.4 Bio-Thera Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Thera Recent Developments/Updates
7.2.6 Bio-Thera Competitive Strengths & Weaknesses
7.3 Zhejiang Hisun
7.3.1 Zhejiang Hisun Details
7.3.2 Zhejiang Hisun Major Business
7.3.3 Zhejiang Hisun Biosimilars Drug Product and Services
7.3.4 Zhejiang Hisun Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Zhejiang Hisun Recent Developments/Updates
7.3.6 Zhejiang Hisun Competitive Strengths & Weaknesses
7.4 Shanghai Henlius
7.4.1 Shanghai Henlius Details
7.4.2 Shanghai Henlius Major Business
7.4.3 Shanghai Henlius Biosimilars Drug Product and Services
7.4.4 Shanghai Henlius Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Shanghai Henlius Recent Developments/Updates
7.4.6 Shanghai Henlius Competitive Strengths & Weaknesses
7.5 Innovent Biologics
7.5.1 Innovent Biologics Details
7.5.2 Innovent Biologics Major Business
7.5.3 Innovent Biologics Biosimilars Drug Product and Services
7.5.4 Innovent Biologics Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Innovent Biologics Recent Developments/Updates
7.5.6 Innovent Biologics Competitive Strengths & Weaknesses
7.6 Jiangsu Hengrui
7.6.1 Jiangsu Hengrui Details
7.6.2 Jiangsu Hengrui Major Business
7.6.3 Jiangsu Hengrui Biosimilars Drug Product and Services
7.6.4 Jiangsu Hengrui Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Jiangsu Hengrui Recent Developments/Updates
7.6.6 Jiangsu Hengrui Competitive Strengths & Weaknesses
7.7 Gan&Lee
7.7.1 Gan&Lee Details
7.7.2 Gan&Lee Major Business
7.7.3 Gan&Lee Biosimilars Drug Product and Services
7.7.4 Gan&Lee Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Gan&Lee Recent Developments/Updates
7.7.6 Gan&Lee Competitive Strengths & Weaknesses
7.8 Tonghua Dongbao
7.8.1 Tonghua Dongbao Details
7.8.2 Tonghua Dongbao Major Business
7.8.3 Tonghua Dongbao Biosimilars Drug Product and Services
7.8.4 Tonghua Dongbao Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Tonghua Dongbao Recent Developments/Updates
7.8.6 Tonghua Dongbao Competitive Strengths & Weaknesses
7.9 United Laboratory
7.9.1 United Laboratory Details
7.9.2 United Laboratory Major Business
7.9.3 United Laboratory Biosimilars Drug Product and Services
7.9.4 United Laboratory Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 United Laboratory Recent Developments/Updates
7.9.6 United Laboratory Competitive Strengths & Weaknesses
7.10 3SBIO
7.10.1 3SBIO Details
7.10.2 3SBIO Major Business
7.10.3 3SBIO Biosimilars Drug Product and Services
7.10.4 3SBIO Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 3SBIO Recent Developments/Updates
7.10.6 3SBIO Competitive Strengths & Weaknesses
7.11 Luye Pharma
7.11.1 Luye Pharma Details
7.11.2 Luye Pharma Major Business
7.11.3 Luye Pharma Biosimilars Drug Product and Services
7.11.4 Luye Pharma Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Luye Pharma Recent Developments/Updates
7.11.6 Luye Pharma Competitive Strengths & Weaknesses
7.12 Celltrion
7.12.1 Celltrion Details
7.12.2 Celltrion Major Business
7.12.3 Celltrion Biosimilars Drug Product and Services
7.12.4 Celltrion Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Celltrion Recent Developments/Updates
7.12.6 Celltrion Competitive Strengths & Weaknesses
7.13 Pfizer
7.13.1 Pfizer Details
7.13.2 Pfizer Major Business
7.13.3 Pfizer Biosimilars Drug Product and Services
7.13.4 Pfizer Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Pfizer Recent Developments/Updates
7.13.6 Pfizer Competitive Strengths & Weaknesses
7.14 Novartis
7.14.1 Novartis Details
7.14.2 Novartis Major Business
7.14.3 Novartis Biosimilars Drug Product and Services
7.14.4 Novartis Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Novartis Recent Developments/Updates
7.14.6 Novartis Competitive Strengths & Weaknesses
7.15 Dr Reddy’s
7.15.1 Dr Reddy’s Details
7.15.2 Dr Reddy’s Major Business
7.15.3 Dr Reddy’s Biosimilars Drug Product and Services
7.15.4 Dr Reddy’s Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Dr Reddy’s Recent Developments/Updates
7.15.6 Dr Reddy’s Competitive Strengths & Weaknesses
7.16 Celgen Biopharma
7.16.1 Celgen Biopharma Details
7.16.2 Celgen Biopharma Major Business
7.16.3 Celgen Biopharma Biosimilars Drug Product and Services
7.16.4 Celgen Biopharma Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Celgen Biopharma Recent Developments/Updates
7.16.6 Celgen Biopharma Competitive Strengths & Weaknesses
7.17 Eli Lilly
7.17.1 Eli Lilly Details
7.17.2 Eli Lilly Major Business
7.17.3 Eli Lilly Biosimilars Drug Product and Services
7.17.4 Eli Lilly Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Eli Lilly Recent Developments/Updates
7.17.6 Eli Lilly Competitive Strengths & Weaknesses
7.18 Sanofi
7.18.1 Sanofi Details
7.18.2 Sanofi Major Business
7.18.3 Sanofi Biosimilars Drug Product and Services
7.18.4 Sanofi Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Sanofi Recent Developments/Updates
7.18.6 Sanofi Competitive Strengths & Weaknesses
7.19 Geropharm
7.19.1 Geropharm Details
7.19.2 Geropharm Major Business
7.19.3 Geropharm Biosimilars Drug Product and Services
7.19.4 Geropharm Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Geropharm Recent Developments/Updates
7.19.6 Geropharm Competitive Strengths & Weaknesses
7.20 Biocon
7.20.1 Biocon Details
7.20.2 Biocon Major Business
7.20.3 Biocon Biosimilars Drug Product and Services
7.20.4 Biocon Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Biocon Recent Developments/Updates
7.20.6 Biocon Competitive Strengths & Weaknesses
7.21 Wockhardt
7.21.1 Wockhardt Details
7.21.2 Wockhardt Major Business
7.21.3 Wockhardt Biosimilars Drug Product and Services
7.21.4 Wockhardt Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Wockhardt Recent Developments/Updates
7.21.6 Wockhardt Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biosimilars Drug Industry Chain
8.2 Biosimilars Drug Upstream Analysis
8.3 Biosimilars Drug Midstream Analysis
8.4 Biosimilars Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Biosimilars Drug Introduction
1.2 World Biosimilars Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Biosimilars Drug Total Market by Region (by Headquarter Location)
1.3.1 World Biosimilars Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Biosimilars Drug Market Size (2018-2029)
1.3.3 China Biosimilars Drug Market Size (2018-2029)
1.3.4 Europe Biosimilars Drug Market Size (2018-2029)
1.3.5 Japan Biosimilars Drug Market Size (2018-2029)
1.3.6 South Korea Biosimilars Drug Market Size (2018-2029)
1.3.7 ASEAN Biosimilars Drug Market Size (2018-2029)
1.3.8 India Biosimilars Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biosimilars Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biosimilars Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biosimilars Drug Consumption Value (2018-2029)
2.2 World Biosimilars Drug Consumption Value by Region
2.2.1 World Biosimilars Drug Consumption Value by Region (2018-2023)
2.2.2 World Biosimilars Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Biosimilars Drug Consumption Value (2018-2029)
2.4 China Biosimilars Drug Consumption Value (2018-2029)
2.5 Europe Biosimilars Drug Consumption Value (2018-2029)
2.6 Japan Biosimilars Drug Consumption Value (2018-2029)
2.7 South Korea Biosimilars Drug Consumption Value (2018-2029)
2.8 ASEAN Biosimilars Drug Consumption Value (2018-2029)
2.9 India Biosimilars Drug Consumption Value (2018-2029)
3 WORLD BIOSIMILARS DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Biosimilars Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biosimilars Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biosimilars Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Biosimilars Drug in 2022
3.3 Biosimilars Drug Company Evaluation Quadrant
3.4 Biosimilars Drug Market: Overall Company Footprint Analysis
3.4.1 Biosimilars Drug Market: Region Footprint
3.4.2 Biosimilars Drug Market: Company Product Type Footprint
3.4.3 Biosimilars Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biosimilars Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biosimilars Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Biosimilars Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Biosimilars Drug Consumption Value Comparison
4.2.1 United States VS China: Biosimilars Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biosimilars Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Biosimilars Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Biosimilars Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biosimilars Drug Revenue, (2018-2023)
4.4 China Based Companies Biosimilars Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Biosimilars Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biosimilars Drug Revenue, (2018-2023)
4.5 Rest of World Based Biosimilars Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Biosimilars Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biosimilars Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biosimilars Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibodies
5.2.2 Insulin
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Biosimilars Drug Market Size by Type (2018-2023)
5.3.2 World Biosimilars Drug Market Size by Type (2024-2029)
5.3.3 World Biosimilars Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biosimilars Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Biosimilars Drug Market Size by Application (2018-2023)
6.3.2 World Biosimilars Drug Market Size by Application (2024-2029)
6.3.3 World Biosimilars Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Qilu Pharmaceutical
7.1.1 Qilu Pharmaceutical Details
7.1.2 Qilu Pharmaceutical Major Business
7.1.3 Qilu Pharmaceutical Biosimilars Drug Product and Services
7.1.4 Qilu Pharmaceutical Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Qilu Pharmaceutical Recent Developments/Updates
7.1.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
7.2 Bio-Thera
7.2.1 Bio-Thera Details
7.2.2 Bio-Thera Major Business
7.2.3 Bio-Thera Biosimilars Drug Product and Services
7.2.4 Bio-Thera Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Thera Recent Developments/Updates
7.2.6 Bio-Thera Competitive Strengths & Weaknesses
7.3 Zhejiang Hisun
7.3.1 Zhejiang Hisun Details
7.3.2 Zhejiang Hisun Major Business
7.3.3 Zhejiang Hisun Biosimilars Drug Product and Services
7.3.4 Zhejiang Hisun Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Zhejiang Hisun Recent Developments/Updates
7.3.6 Zhejiang Hisun Competitive Strengths & Weaknesses
7.4 Shanghai Henlius
7.4.1 Shanghai Henlius Details
7.4.2 Shanghai Henlius Major Business
7.4.3 Shanghai Henlius Biosimilars Drug Product and Services
7.4.4 Shanghai Henlius Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Shanghai Henlius Recent Developments/Updates
7.4.6 Shanghai Henlius Competitive Strengths & Weaknesses
7.5 Innovent Biologics
7.5.1 Innovent Biologics Details
7.5.2 Innovent Biologics Major Business
7.5.3 Innovent Biologics Biosimilars Drug Product and Services
7.5.4 Innovent Biologics Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Innovent Biologics Recent Developments/Updates
7.5.6 Innovent Biologics Competitive Strengths & Weaknesses
7.6 Jiangsu Hengrui
7.6.1 Jiangsu Hengrui Details
7.6.2 Jiangsu Hengrui Major Business
7.6.3 Jiangsu Hengrui Biosimilars Drug Product and Services
7.6.4 Jiangsu Hengrui Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Jiangsu Hengrui Recent Developments/Updates
7.6.6 Jiangsu Hengrui Competitive Strengths & Weaknesses
7.7 Gan&Lee
7.7.1 Gan&Lee Details
7.7.2 Gan&Lee Major Business
7.7.3 Gan&Lee Biosimilars Drug Product and Services
7.7.4 Gan&Lee Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Gan&Lee Recent Developments/Updates
7.7.6 Gan&Lee Competitive Strengths & Weaknesses
7.8 Tonghua Dongbao
7.8.1 Tonghua Dongbao Details
7.8.2 Tonghua Dongbao Major Business
7.8.3 Tonghua Dongbao Biosimilars Drug Product and Services
7.8.4 Tonghua Dongbao Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Tonghua Dongbao Recent Developments/Updates
7.8.6 Tonghua Dongbao Competitive Strengths & Weaknesses
7.9 United Laboratory
7.9.1 United Laboratory Details
7.9.2 United Laboratory Major Business
7.9.3 United Laboratory Biosimilars Drug Product and Services
7.9.4 United Laboratory Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 United Laboratory Recent Developments/Updates
7.9.6 United Laboratory Competitive Strengths & Weaknesses
7.10 3SBIO
7.10.1 3SBIO Details
7.10.2 3SBIO Major Business
7.10.3 3SBIO Biosimilars Drug Product and Services
7.10.4 3SBIO Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 3SBIO Recent Developments/Updates
7.10.6 3SBIO Competitive Strengths & Weaknesses
7.11 Luye Pharma
7.11.1 Luye Pharma Details
7.11.2 Luye Pharma Major Business
7.11.3 Luye Pharma Biosimilars Drug Product and Services
7.11.4 Luye Pharma Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Luye Pharma Recent Developments/Updates
7.11.6 Luye Pharma Competitive Strengths & Weaknesses
7.12 Celltrion
7.12.1 Celltrion Details
7.12.2 Celltrion Major Business
7.12.3 Celltrion Biosimilars Drug Product and Services
7.12.4 Celltrion Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Celltrion Recent Developments/Updates
7.12.6 Celltrion Competitive Strengths & Weaknesses
7.13 Pfizer
7.13.1 Pfizer Details
7.13.2 Pfizer Major Business
7.13.3 Pfizer Biosimilars Drug Product and Services
7.13.4 Pfizer Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Pfizer Recent Developments/Updates
7.13.6 Pfizer Competitive Strengths & Weaknesses
7.14 Novartis
7.14.1 Novartis Details
7.14.2 Novartis Major Business
7.14.3 Novartis Biosimilars Drug Product and Services
7.14.4 Novartis Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Novartis Recent Developments/Updates
7.14.6 Novartis Competitive Strengths & Weaknesses
7.15 Dr Reddy’s
7.15.1 Dr Reddy’s Details
7.15.2 Dr Reddy’s Major Business
7.15.3 Dr Reddy’s Biosimilars Drug Product and Services
7.15.4 Dr Reddy’s Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Dr Reddy’s Recent Developments/Updates
7.15.6 Dr Reddy’s Competitive Strengths & Weaknesses
7.16 Celgen Biopharma
7.16.1 Celgen Biopharma Details
7.16.2 Celgen Biopharma Major Business
7.16.3 Celgen Biopharma Biosimilars Drug Product and Services
7.16.4 Celgen Biopharma Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Celgen Biopharma Recent Developments/Updates
7.16.6 Celgen Biopharma Competitive Strengths & Weaknesses
7.17 Eli Lilly
7.17.1 Eli Lilly Details
7.17.2 Eli Lilly Major Business
7.17.3 Eli Lilly Biosimilars Drug Product and Services
7.17.4 Eli Lilly Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Eli Lilly Recent Developments/Updates
7.17.6 Eli Lilly Competitive Strengths & Weaknesses
7.18 Sanofi
7.18.1 Sanofi Details
7.18.2 Sanofi Major Business
7.18.3 Sanofi Biosimilars Drug Product and Services
7.18.4 Sanofi Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Sanofi Recent Developments/Updates
7.18.6 Sanofi Competitive Strengths & Weaknesses
7.19 Geropharm
7.19.1 Geropharm Details
7.19.2 Geropharm Major Business
7.19.3 Geropharm Biosimilars Drug Product and Services
7.19.4 Geropharm Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Geropharm Recent Developments/Updates
7.19.6 Geropharm Competitive Strengths & Weaknesses
7.20 Biocon
7.20.1 Biocon Details
7.20.2 Biocon Major Business
7.20.3 Biocon Biosimilars Drug Product and Services
7.20.4 Biocon Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Biocon Recent Developments/Updates
7.20.6 Biocon Competitive Strengths & Weaknesses
7.21 Wockhardt
7.21.1 Wockhardt Details
7.21.2 Wockhardt Major Business
7.21.3 Wockhardt Biosimilars Drug Product and Services
7.21.4 Wockhardt Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Wockhardt Recent Developments/Updates
7.21.6 Wockhardt Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biosimilars Drug Industry Chain
8.2 Biosimilars Drug Upstream Analysis
8.3 Biosimilars Drug Midstream Analysis
8.4 Biosimilars Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Biosimilars Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Biosimilars Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Biosimilars Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Biosimilars Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Biosimilars Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biosimilars Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Biosimilars Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Biosimilars Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Biosimilars Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Biosimilars Drug Players in 2022
Table 12. World Biosimilars Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Biosimilars Drug Company Evaluation Quadrant
Table 14. Head Office of Key Biosimilars Drug Player
Table 15. Biosimilars Drug Market: Company Product Type Footprint
Table 16. Biosimilars Drug Market: Company Product Application Footprint
Table 17. Biosimilars Drug Mergers & Acquisitions Activity
Table 18. United States VS China Biosimilars Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Biosimilars Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Biosimilars Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biosimilars Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Biosimilars Drug Revenue Market Share (2018-2023)
Table 23. China Based Biosimilars Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biosimilars Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Biosimilars Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Biosimilars Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biosimilars Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Biosimilars Drug Revenue Market Share (2018-2023)
Table 29. World Biosimilars Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Biosimilars Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Biosimilars Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Biosimilars Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Biosimilars Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Biosimilars Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Qilu Pharmaceutical Basic Information, Area Served and Competitors
Table 36. Qilu Pharmaceutical Major Business
Table 37. Qilu Pharmaceutical Biosimilars Drug Product and Services
Table 38. Qilu Pharmaceutical Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Qilu Pharmaceutical Recent Developments/Updates
Table 40. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 41. Bio-Thera Basic Information, Area Served and Competitors
Table 42. Bio-Thera Major Business
Table 43. Bio-Thera Biosimilars Drug Product and Services
Table 44. Bio-Thera Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bio-Thera Recent Developments/Updates
Table 46. Bio-Thera Competitive Strengths & Weaknesses
Table 47. Zhejiang Hisun Basic Information, Area Served and Competitors
Table 48. Zhejiang Hisun Major Business
Table 49. Zhejiang Hisun Biosimilars Drug Product and Services
Table 50. Zhejiang Hisun Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Zhejiang Hisun Recent Developments/Updates
Table 52. Zhejiang Hisun Competitive Strengths & Weaknesses
Table 53. Shanghai Henlius Basic Information, Area Served and Competitors
Table 54. Shanghai Henlius Major Business
Table 55. Shanghai Henlius Biosimilars Drug Product and Services
Table 56. Shanghai Henlius Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Shanghai Henlius Recent Developments/Updates
Table 58. Shanghai Henlius Competitive Strengths & Weaknesses
Table 59. Innovent Biologics Basic Information, Area Served and Competitors
Table 60. Innovent Biologics Major Business
Table 61. Innovent Biologics Biosimilars Drug Product and Services
Table 62. Innovent Biologics Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Innovent Biologics Recent Developments/Updates
Table 64. Innovent Biologics Competitive Strengths & Weaknesses
Table 65. Jiangsu Hengrui Basic Information, Area Served and Competitors
Table 66. Jiangsu Hengrui Major Business
Table 67. Jiangsu Hengrui Biosimilars Drug Product and Services
Table 68. Jiangsu Hengrui Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Jiangsu Hengrui Recent Developments/Updates
Table 70. Jiangsu Hengrui Competitive Strengths & Weaknesses
Table 71. Gan&Lee Basic Information, Area Served and Competitors
Table 72. Gan&Lee Major Business
Table 73. Gan&Lee Biosimilars Drug Product and Services
Table 74. Gan&Lee Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Gan&Lee Recent Developments/Updates
Table 76. Gan&Lee Competitive Strengths & Weaknesses
Table 77. Tonghua Dongbao Basic Information, Area Served and Competitors
Table 78. Tonghua Dongbao Major Business
Table 79. Tonghua Dongbao Biosimilars Drug Product and Services
Table 80. Tonghua Dongbao Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Tonghua Dongbao Recent Developments/Updates
Table 82. Tonghua Dongbao Competitive Strengths & Weaknesses
Table 83. United Laboratory Basic Information, Area Served and Competitors
Table 84. United Laboratory Major Business
Table 85. United Laboratory Biosimilars Drug Product and Services
Table 86. United Laboratory Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. United Laboratory Recent Developments/Updates
Table 88. United Laboratory Competitive Strengths & Weaknesses
Table 89. 3SBIO Basic Information, Area Served and Competitors
Table 90. 3SBIO Major Business
Table 91. 3SBIO Biosimilars Drug Product and Services
Table 92. 3SBIO Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. 3SBIO Recent Developments/Updates
Table 94. 3SBIO Competitive Strengths & Weaknesses
Table 95. Luye Pharma Basic Information, Area Served and Competitors
Table 96. Luye Pharma Major Business
Table 97. Luye Pharma Biosimilars Drug Product and Services
Table 98. Luye Pharma Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Luye Pharma Recent Developments/Updates
Table 100. Luye Pharma Competitive Strengths & Weaknesses
Table 101. Celltrion Basic Information, Area Served and Competitors
Table 102. Celltrion Major Business
Table 103. Celltrion Biosimilars Drug Product and Services
Table 104. Celltrion Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Celltrion Recent Developments/Updates
Table 106. Celltrion Competitive Strengths & Weaknesses
Table 107. Pfizer Basic Information, Area Served and Competitors
Table 108. Pfizer Major Business
Table 109. Pfizer Biosimilars Drug Product and Services
Table 110. Pfizer Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Pfizer Recent Developments/Updates
Table 112. Pfizer Competitive Strengths & Weaknesses
Table 113. Novartis Basic Information, Area Served and Competitors
Table 114. Novartis Major Business
Table 115. Novartis Biosimilars Drug Product and Services
Table 116. Novartis Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Novartis Recent Developments/Updates
Table 118. Novartis Competitive Strengths & Weaknesses
Table 119. Dr Reddy’s Basic Information, Area Served and Competitors
Table 120. Dr Reddy’s Major Business
Table 121. Dr Reddy’s Biosimilars Drug Product and Services
Table 122. Dr Reddy’s Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Dr Reddy’s Recent Developments/Updates
Table 124. Dr Reddy’s Competitive Strengths & Weaknesses
Table 125. Celgen Biopharma Basic Information, Area Served and Competitors
Table 126. Celgen Biopharma Major Business
Table 127. Celgen Biopharma Biosimilars Drug Product and Services
Table 128. Celgen Biopharma Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Celgen Biopharma Recent Developments/Updates
Table 130. Celgen Biopharma Competitive Strengths & Weaknesses
Table 131. Eli Lilly Basic Information, Area Served and Competitors
Table 132. Eli Lilly Major Business
Table 133. Eli Lilly Biosimilars Drug Product and Services
Table 134. Eli Lilly Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Eli Lilly Recent Developments/Updates
Table 136. Eli Lilly Competitive Strengths & Weaknesses
Table 137. Sanofi Basic Information, Area Served and Competitors
Table 138. Sanofi Major Business
Table 139. Sanofi Biosimilars Drug Product and Services
Table 140. Sanofi Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Sanofi Recent Developments/Updates
Table 142. Sanofi Competitive Strengths & Weaknesses
Table 143. Geropharm Basic Information, Area Served and Competitors
Table 144. Geropharm Major Business
Table 145. Geropharm Biosimilars Drug Product and Services
Table 146. Geropharm Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Geropharm Recent Developments/Updates
Table 148. Geropharm Competitive Strengths & Weaknesses
Table 149. Biocon Basic Information, Area Served and Competitors
Table 150. Biocon Major Business
Table 151. Biocon Biosimilars Drug Product and Services
Table 152. Biocon Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Biocon Recent Developments/Updates
Table 154. Wockhardt Basic Information, Area Served and Competitors
Table 155. Wockhardt Major Business
Table 156. Wockhardt Biosimilars Drug Product and Services
Table 157. Wockhardt Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 158. Global Key Players of Biosimilars Drug Upstream (Raw Materials)
Table 159. Biosimilars Drug Typical Customers
Table 1. World Biosimilars Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Biosimilars Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Biosimilars Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Biosimilars Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Biosimilars Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biosimilars Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Biosimilars Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Biosimilars Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Biosimilars Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Biosimilars Drug Players in 2022
Table 12. World Biosimilars Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Biosimilars Drug Company Evaluation Quadrant
Table 14. Head Office of Key Biosimilars Drug Player
Table 15. Biosimilars Drug Market: Company Product Type Footprint
Table 16. Biosimilars Drug Market: Company Product Application Footprint
Table 17. Biosimilars Drug Mergers & Acquisitions Activity
Table 18. United States VS China Biosimilars Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Biosimilars Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Biosimilars Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biosimilars Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Biosimilars Drug Revenue Market Share (2018-2023)
Table 23. China Based Biosimilars Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biosimilars Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Biosimilars Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Biosimilars Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biosimilars Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Biosimilars Drug Revenue Market Share (2018-2023)
Table 29. World Biosimilars Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Biosimilars Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Biosimilars Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Biosimilars Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Biosimilars Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Biosimilars Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Qilu Pharmaceutical Basic Information, Area Served and Competitors
Table 36. Qilu Pharmaceutical Major Business
Table 37. Qilu Pharmaceutical Biosimilars Drug Product and Services
Table 38. Qilu Pharmaceutical Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Qilu Pharmaceutical Recent Developments/Updates
Table 40. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 41. Bio-Thera Basic Information, Area Served and Competitors
Table 42. Bio-Thera Major Business
Table 43. Bio-Thera Biosimilars Drug Product and Services
Table 44. Bio-Thera Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bio-Thera Recent Developments/Updates
Table 46. Bio-Thera Competitive Strengths & Weaknesses
Table 47. Zhejiang Hisun Basic Information, Area Served and Competitors
Table 48. Zhejiang Hisun Major Business
Table 49. Zhejiang Hisun Biosimilars Drug Product and Services
Table 50. Zhejiang Hisun Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Zhejiang Hisun Recent Developments/Updates
Table 52. Zhejiang Hisun Competitive Strengths & Weaknesses
Table 53. Shanghai Henlius Basic Information, Area Served and Competitors
Table 54. Shanghai Henlius Major Business
Table 55. Shanghai Henlius Biosimilars Drug Product and Services
Table 56. Shanghai Henlius Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Shanghai Henlius Recent Developments/Updates
Table 58. Shanghai Henlius Competitive Strengths & Weaknesses
Table 59. Innovent Biologics Basic Information, Area Served and Competitors
Table 60. Innovent Biologics Major Business
Table 61. Innovent Biologics Biosimilars Drug Product and Services
Table 62. Innovent Biologics Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Innovent Biologics Recent Developments/Updates
Table 64. Innovent Biologics Competitive Strengths & Weaknesses
Table 65. Jiangsu Hengrui Basic Information, Area Served and Competitors
Table 66. Jiangsu Hengrui Major Business
Table 67. Jiangsu Hengrui Biosimilars Drug Product and Services
Table 68. Jiangsu Hengrui Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Jiangsu Hengrui Recent Developments/Updates
Table 70. Jiangsu Hengrui Competitive Strengths & Weaknesses
Table 71. Gan&Lee Basic Information, Area Served and Competitors
Table 72. Gan&Lee Major Business
Table 73. Gan&Lee Biosimilars Drug Product and Services
Table 74. Gan&Lee Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Gan&Lee Recent Developments/Updates
Table 76. Gan&Lee Competitive Strengths & Weaknesses
Table 77. Tonghua Dongbao Basic Information, Area Served and Competitors
Table 78. Tonghua Dongbao Major Business
Table 79. Tonghua Dongbao Biosimilars Drug Product and Services
Table 80. Tonghua Dongbao Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Tonghua Dongbao Recent Developments/Updates
Table 82. Tonghua Dongbao Competitive Strengths & Weaknesses
Table 83. United Laboratory Basic Information, Area Served and Competitors
Table 84. United Laboratory Major Business
Table 85. United Laboratory Biosimilars Drug Product and Services
Table 86. United Laboratory Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. United Laboratory Recent Developments/Updates
Table 88. United Laboratory Competitive Strengths & Weaknesses
Table 89. 3SBIO Basic Information, Area Served and Competitors
Table 90. 3SBIO Major Business
Table 91. 3SBIO Biosimilars Drug Product and Services
Table 92. 3SBIO Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. 3SBIO Recent Developments/Updates
Table 94. 3SBIO Competitive Strengths & Weaknesses
Table 95. Luye Pharma Basic Information, Area Served and Competitors
Table 96. Luye Pharma Major Business
Table 97. Luye Pharma Biosimilars Drug Product and Services
Table 98. Luye Pharma Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Luye Pharma Recent Developments/Updates
Table 100. Luye Pharma Competitive Strengths & Weaknesses
Table 101. Celltrion Basic Information, Area Served and Competitors
Table 102. Celltrion Major Business
Table 103. Celltrion Biosimilars Drug Product and Services
Table 104. Celltrion Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Celltrion Recent Developments/Updates
Table 106. Celltrion Competitive Strengths & Weaknesses
Table 107. Pfizer Basic Information, Area Served and Competitors
Table 108. Pfizer Major Business
Table 109. Pfizer Biosimilars Drug Product and Services
Table 110. Pfizer Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Pfizer Recent Developments/Updates
Table 112. Pfizer Competitive Strengths & Weaknesses
Table 113. Novartis Basic Information, Area Served and Competitors
Table 114. Novartis Major Business
Table 115. Novartis Biosimilars Drug Product and Services
Table 116. Novartis Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Novartis Recent Developments/Updates
Table 118. Novartis Competitive Strengths & Weaknesses
Table 119. Dr Reddy’s Basic Information, Area Served and Competitors
Table 120. Dr Reddy’s Major Business
Table 121. Dr Reddy’s Biosimilars Drug Product and Services
Table 122. Dr Reddy’s Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Dr Reddy’s Recent Developments/Updates
Table 124. Dr Reddy’s Competitive Strengths & Weaknesses
Table 125. Celgen Biopharma Basic Information, Area Served and Competitors
Table 126. Celgen Biopharma Major Business
Table 127. Celgen Biopharma Biosimilars Drug Product and Services
Table 128. Celgen Biopharma Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Celgen Biopharma Recent Developments/Updates
Table 130. Celgen Biopharma Competitive Strengths & Weaknesses
Table 131. Eli Lilly Basic Information, Area Served and Competitors
Table 132. Eli Lilly Major Business
Table 133. Eli Lilly Biosimilars Drug Product and Services
Table 134. Eli Lilly Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Eli Lilly Recent Developments/Updates
Table 136. Eli Lilly Competitive Strengths & Weaknesses
Table 137. Sanofi Basic Information, Area Served and Competitors
Table 138. Sanofi Major Business
Table 139. Sanofi Biosimilars Drug Product and Services
Table 140. Sanofi Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Sanofi Recent Developments/Updates
Table 142. Sanofi Competitive Strengths & Weaknesses
Table 143. Geropharm Basic Information, Area Served and Competitors
Table 144. Geropharm Major Business
Table 145. Geropharm Biosimilars Drug Product and Services
Table 146. Geropharm Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Geropharm Recent Developments/Updates
Table 148. Geropharm Competitive Strengths & Weaknesses
Table 149. Biocon Basic Information, Area Served and Competitors
Table 150. Biocon Major Business
Table 151. Biocon Biosimilars Drug Product and Services
Table 152. Biocon Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Biocon Recent Developments/Updates
Table 154. Wockhardt Basic Information, Area Served and Competitors
Table 155. Wockhardt Major Business
Table 156. Wockhardt Biosimilars Drug Product and Services
Table 157. Wockhardt Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 158. Global Key Players of Biosimilars Drug Upstream (Raw Materials)
Table 159. Biosimilars Drug Typical Customers
LIST OF FIGURES
Figure 1. Biosimilars Drug Picture
Figure 2. World Biosimilars Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biosimilars Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Biosimilars Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Biosimilars Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 13. Biosimilars Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Biosimilars Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Biosimilars Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biosimilars Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biosimilars Drug Markets in 2022
Figure 27. United States VS China: Biosimilars Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biosimilars Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Biosimilars Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Biosimilars Drug Market Size Market Share by Type in 2022
Figure 31. Monoclonal Antibodies
Figure 32. Insulin
Figure 33. Others
Figure 34. World Biosimilars Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Biosimilars Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Biosimilars Drug Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Retail Pharmacy
Figure 39. Other
Figure 40. Biosimilars Drug Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Biosimilars Drug Picture
Figure 2. World Biosimilars Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biosimilars Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Biosimilars Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Biosimilars Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Biosimilars Drug Revenue (2018-2029) & (USD Million)
Figure 13. Biosimilars Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Biosimilars Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Biosimilars Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biosimilars Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biosimilars Drug Markets in 2022
Figure 27. United States VS China: Biosimilars Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biosimilars Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Biosimilars Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Biosimilars Drug Market Size Market Share by Type in 2022
Figure 31. Monoclonal Antibodies
Figure 32. Insulin
Figure 33. Others
Figure 34. World Biosimilars Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Biosimilars Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Biosimilars Drug Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Retail Pharmacy
Figure 39. Other
Figure 40. Biosimilars Drug Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
